CDKN2A and diffuse large B-cell lymphoma: RT has a genomic complexity situated between the genomic complexity of CLL and DLBCL [10], and inactivation of tumor protein p53 (TP53) and cyclin-dependent kinase inhibitor 2A (CDKN2A) was found in half the cases [11].